So this is a big step forward and we welcome the positive opinion given by the European Medicines Agency (EMA),” said Gregory Hartl, WHO’s spokesperson for Avian Influenza and other epidemic diseases. The next step, the advice will be reviewed by WHO in October. GlaxoSmithKline (GSK) has spent more than USD 356 million to date on finding a vaccine. Malaria kills around 600,000 people a year worldwide, and most of them are children under five in sub-Saharan Africa. The disease is transmitted most commonly by an infected female Anopheles mosquito. Insecticides will continue to be needed and the protection given will be only partial.
